Sarepta Therapeutics competitorsClear all

Sarepta Therapeutics's top competitors include Ionis Pharmaceuticals, Moderna, Intarcia Therapeutics, CureVac, Alnylam Pharmaceuticals and Regulus Therapeutics.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Sarepta Therapeutics
Sarepta Therapeutics
Sarepta Therapeutics is a biopharmaceutical company focused on developing innovative RNA-targeted therapeutics.
Ionis Pharmaceuticals
Ionis Pharmaceuticals
Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.
Moderna
Moderna
Moderna Therapeutics develops messenger RNA therapeutics that produces human proteins for antibodies inside patient cells.
Intarcia Therapeutics
Intarcia Therapeutics
Intarcia Therapeutics is a biopharmaceutical company developing innovative therapies for chronic diseases.
CureVac
CureVac
CureVac is a biotechnology company that is active in the field of messenger RNA (mRNA) technology.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.
Founding Date
Founding Date
1980
Founding Date
1989
Founding Date
N/A
Founding Date
1997
Founding Date
2000
Founding Date
2002
Founding Date
2007
Type
Type
Public
Type
Public
Type
Public
Type
Private
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Boulogne Billancourt, FR
Berlin, DE
Dublin, IE
Milano, IT
Chiyoda City, JP
see more
Locations
Carlsbad, US HQ
Locations
Cambridge, US HQ
Huddinge, SE
Cambridge, US
Norwood, US
Locations
Boston, US HQ
Durham, US
Hayward, US
Locations
Tübingen, DE HQ
Frankfurt Am Main, DE
Tübingen, DE
Boston, US
Locations
Cambridge, US HQ
Paris, FR
Milano, IT
Amsterdam, NL
Stockholm, SE
Zug, CH
Maidenhead, GB
Locations
San Diego, US HQ
Employees
Employees
74349% increase
Employees
7577% decrease
Employees
8309% increase
Employees
1241% decrease
Employees
4004% increase
Employees
1,32324% increase
Employees
2462% decrease
Valuation ($)
Valuation ($)
7 b
Valuation ($)
5.2 b
Valuation ($)
177.9 b
Valuation ($)
3.9 b
Valuation ($)
1.5 b
Valuation ($)
21.7 b
Valuation ($)
64.9 m
Twitter followers
Twitter followers
3.7 k
Twitter followers
3.5 k
Twitter followers
130.2 k
Twitter followers
535
Twitter followers
5
Twitter followers
14.3 k
Twitter followers
802
Number of tweets (last 30 days)
Number of tweets (last 30 days)
28
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
44
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
14
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
9.6
Average likes per tweet (last 30 days)
5.5
Average likes per tweet (last 30 days)
612.2
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
7.9
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
181719
Alexa Website Rank
280538
Alexa Website Rank
67329
Alexa Website Rank
556907
Alexa Website Rank
174129
Alexa Website Rank
271609
Alexa Website Rank
393437
Employee Rating
Employee Rating
3.5
Employee Rating
3.7
Employee Rating
4.2
Employee Rating
3.6
Employee Rating
3.9
Employee Rating
4.2
Employee Rating
2.8

Financial

Revenue (est.)
Revenue (est.)
$540.1m (FY, 2020)
Revenue (est.)
$729.3m (FY, 2020)
Revenue (est.)
$803.4m (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
€12.6m (FY, 2018)
Revenue (est.)
$492.9m (FY, 2020)
Revenue (est.)
$10m (FY, 2020)
Cost of goods
Cost of goods
N/A
Cost of goods
$11.9m (FY, 2020)
Cost of goods
$7.9m (FY, 2020)
Cost of goods
N/A
Cost of goods
€22.3m (FY, 2018)
Cost of goods
$78.1m (FY, 2020)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$717.3m (FY, 2020)
Gross profit
$795.5m (FY, 2020)
Gross profit
N/A
Gross profit
(€9.8m) (FY, 2018)
Gross profit
$414.8m (FY, 2020)
Gross profit
N/A
Net income
Net income
($554.1m) (FY, 2020)
Net income
($486.8m) (FY, 2020)
Net income
($747.1m) (FY, 2020)
Net income
N/A
Net income
(€74.6m) (FY, 2018)
Net income
($858.3m) (FY, 2020)
Net income
($15.7m) (FY, 2020)

Operating

Patent Applications
Patent Applications
N/A
Patent Applications
N/A
Patent Applications
250 (May, 2017)
Patent Applications
N/A
Patent Applications
500 (Mar, 2020)
Patent Applications
N/A
Patent Applications
N/A
Patents Issued
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
100 (Q3, 2018)
Patents Issued
N/A
Patents Issued
233 (May, 2020)
Patents Issued
N/A
Patents Issued
300 (FY, 2016)
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
6 (FY, 2020)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
3 (May, 2020)
Phase I Trials Products
N/A
Phase I Trials Products
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 73.1m (over 2 years ago)
Latest funding round
$ 640m (about 1 year ago)
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 1.8b
Total funding raised
$ 1.8b
Total funding raised
$ 1.1b
Total funding raised
$ 1.5b
Total funding raised
$ 10m
For sources of this data, please see the company profile

View company profiles

Ionis Pharmaceuticals
HQ
Carlsbad, US
Employees
757↓ 7% decrease

Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.

View company
Moderna
HQ
Cambridge, US
Employees
830↑ 9% increase

Moderna Therapeutics develops messenger RNA therapeutics that produces human proteins for antibodies inside patient cells.

View company
Intarcia Therapeutics
HQ
Boston, US
Employees
124↓ 1% decrease

Intarcia Therapeutics is a biopharmaceutical company developing innovative therapies for chronic diseases.

View company
CureVac
HQ
Tübingen, DE
Employees
400↑ 4% increase

CureVac is a biotechnology company that is active in the field of messenger RNA (mRNA) technology.

View company